Skip to content
Search the site

CBD Oil

What Is CBD Oil? How It’s Made, What It Does and Its Status in Turkey (2026)

We explain in plain language what CBD oil is, how it’s made, how to read its label and what research has found.

By: cbd.school editorial teamUpdated: 36 sources

3D ball-and-stick model of the cannabidiol (CBD) molecule: carbon gray, oxygen red, hydrogen white
Image: cbd.com.tr · from the PubChem CID 644019 3D conformer · CC BY 4.0: you may use it with a link back

You may have seen a small CBD oil bottle with a dropper in the news or in the hands of someone you know. It’s only natural to wonder what’s inside, how it’s made, what the label tells you and whether it really works. This page covers CBD oil as a product: how it’s made, its types, its label, what research has found, possible side effects and the rules in Turkey. For CBD itself as a substance, see What is CBD?; for details by condition, see the CBD Guide.

What’s in this article?14 sections

At a glance: CBD oil

What is it?

CBD (cannabidiol) extract mixed with a carrier oil

How is it used?

Mostly by mouth, as drops

Types

Full-spectrum, broad-spectrum, isolate (sales terms with no binding official definition)

Is it the same as seed oil?

No; seed oil contains only very small amounts of CBD

Where research is strongest

Dravet, Lennox–Gastaut and tuberous sclerosis (with the approved medicine)

Things to watch

Drug interactions, liver test results, drowsiness, THC not listed on the label

In Turkey

Can be sold only in pharmacies; no approved CBD medicine (October 2026)

What is CBD oil?

CBD oil is CBD from the cannabis plant (Cannabis sativa) dissolved in an oil. CBD dissolves in oil, not water, so most products are oil-based. The approved CBD medicine is actually a CBD oil, too: each milliliter contains 100 mg of purified CBD, with sesame oil as the carrier and a small amount of alcohol (Epidiolex label, 2026).

3D ball-and-stick model of CBD (left) and caprylic acid (right): caprylic acid is the main fatty acid in MCT oil; carbon gray, oxygen red, hydrogen white
CBD (left) dissolves in oil, not water, which is why it is sold in a carrier oil such as olive oil or MCT. On the right is caprylic acid, the main fatty acid in MCT oil. Image: cbd.com.tr · PubChem CID 644019 and 379 (CC BY 4.0)

It may also be sold as "CBD drops," "tincture" or "hemp extract." Whatever the name, what matters is that the label states how many mg of CBD are in the bottle and in 1 ml. In an analysis of 50 products sold in the US as "CBD oil / hemp oil," most of the products contained less than 0.1% CBD (ElSohly 2020).

How it differs from hemp seed oil

Hemp seed oil is a food oil made by pressing the seeds. CBD, by contrast, comes from the plant’s flowers and leaves; Turkey’s cultivation regulation also governs these parts separately from the seeds and fiber (Official Gazette, January 31, 2026). In a study of 20 hemp seed oils sold in Turkey, CBD came out at no more than about 0.02 mg per milliliter; small amounts of THC were also measured in all but one of the samples (Kacargil 2026). If the bottle doesn’t state how many mg of CBD it contains, the product shouldn’t be considered a CBD oil. More detail: CBD oil or hemp seed oil?

How many drops of CBD oil?

Turn the dose your doctor prescribed into drops.

1. How many mg of CBD are in the bottle?

2. How many ml is the bottle?

3. How many mg did your doctor prescribe?

25 mg

For 25 mg

5 drops

Each drop contains about 5 mg of CBD.

Your doctor decides the dose. This tool only shows how many drops that is.

For another bottle, a percentage (%) or a syringe

A short history

Year

What happened?

1940

In the US, Roger Adams and his team isolated CBD from cannabis extract (Adams 1940).

1963

Raphael Mechoulam and Yuval Shvo worked out the chemical structure of CBD (Mechoulam and Shvo 1963).

2018

The US approved its first licensed CBD medicine (Epidiolex). The World Health Organization’s expert committee reported that CBD showed no potential for abuse or dependence in humans (WHO 2018).

2019

The same medicine was licensed in Europe under the name Epidyolex (EMA, September 19, 2019).

2025

In Turkey, Law No. 7557 established that hemp-derived products may be sold only in pharmacies.

2026

The Kenevirden Elde Edilen Ürünlere Dair Yönetmelik (Regulation on Products Derived from Hemp) was published (January 31). The European Food Safety Authority (EFSA) announced a provisional safe level for CBD in food supplements.

How is CBD oil made?

A CBD-rich extract is taken from the plant, refined if needed and diluted with a carrier oil to the desired strength. Each step affects what ends up in the bottle.

  1. Plant: The flowers and leaves of CBD-rich hemp varieties are used. In the plant, CBD is first present in its acid form (CBDA).
  2. Extraction: The cannabinoids in the dried plant are drawn out with a solvent; the most common method is extraction with solvents such as ethanol (Lazarjani 2021). In extraction with carbon dioxide under high pressure (supercritical CO2), the carbon dioxide separates out as a gas at the end of the process, leaving no solvent in the product (Qamar 2021).
  3. Heating: Heat, light and air convert CBDA into CBD (Citti 2018). In 50 products tested in the US, almost all of the CBD had gone through this conversion (ElSohly 2020). That is why CBD and CBDA appear on separate lines of the certificate of analysis.
  4. Refining: The crude extract is cleaned of unwanted plant material. The further the refining goes, the closer the extract gets to nearly pure CBD (isolate).
  5. Dilution: The extract or isolate is mixed with a carrier such as MCT (medium-chain triglyceride) oil, olive oil, sesame oil or hemp seed oil. This ratio determines the amount of CBD in the bottle.
  6. Testing: Every batch needs to be tested for CBD, THC and contaminants. In Turkey, a "support product" license requires a report from an accredited laboratory showing that the THC limit has not been exceeded (Regulation, 2026).

If production isn’t well controlled, solvent can remain in the product. In Australia, 29% of the unregulated cannabis products used by children with epilepsy had ethanol or isopropanol residues above the accepted limit (Suraev 2022). In the US, solvent residues were found in 181 of 202 CBD products, though few measurements exceeded the limit (Gidal 2024). Details on extraction methods: How is CBD oil produced?

CBD can also be made chemically in the lab. EFSA found synthetic CBD that is at least 98% pure and dissolved in MCT oil to be safe at up to 2 mg a day, and only for adults over 25 who are not pregnant or breastfeeding; safety could not be established for people taking medicines (EFSA 2026).

Full-spectrum, broad-spectrum, isolate

These three terms describe how much the extract has been refined. They have no binding official definitions, and the type stated on the label is not always accurate.

Type

What it means

Good to know

Full-spectrum

An extract said to contain other cannabinoids and a small amount of THC alongside CBD

Even a small amount of THC could turn a urine test positive with regular use (Wolinsky 2026)

Broad-spectrum

An extract said to have had its THC removed while keeping the other cannabinoids

In volunteers who used it for 10 weeks, CBG and CBDV, which the World Anti-Doping Agency banned at the time, were detected in urine (Gillham 2026)

Isolate

Purified CBD on its own

Both the approved medicine and the CBD that EFSA evaluated are of this type

In a study of 202 products in the US, 26% did not match the type stated on their label; three of the study’s authors work for the company that makes the approved CBD medicine (Gidal 2024). The idea that the plant’s compounds work better together is called the "entourage effect." This idea has not been proven in humans. The most cited study is an analysis that pooled observational data without a control group in drug-resistant epilepsy: patients reported "improvement" more often with plant extracts, but by the measure of seizures falling by at least half there was no difference between the two groups (37% vs. 42%); the authors write that the result needs to be confirmed in controlled studies (Pamplona 2018). A review also stresses that the concept is poorly defined and is often used to sell products (Cogan 2020). More detail: CBD spectrum guide.

What does the research say?

CBD Guide reviews the research on each condition one by one. In the most reliable studies, patients are randomly assigned to groups; one group takes CBD and the other takes an inactive look-alike (placebo). Here is where things stand today for pure CBD:

The full table and the strength of evidence for each topic are on the What is CBD? page and in the guide. Results for products containing THC are assessed separately. Most studies used pharmaceutical-grade CBD of known content; these results can’t be applied directly to oils whose content isn’t checked.

Epilepsy: The approved CBD medicine reduced seizures when added to existing medicines. In children and young people with Dravet syndrome, the median number of seizures per month fell from 12.4 to 5.9, compared with 14.9 to 14.1 in the placebo group (Devinsky 2017). In Lennox–Gastaut syndrome, drop seizures fell by 43.9% with the medicine and by 21.8% with placebo (Thiele 2018).

Pain and sleep: In 15 of 16 pain studies using pharmaceutical-grade CBD, there was no clear difference between people taking CBD and those taking placebo (Moore 2024). A 2025 analysis pooling many studies found no clear difference in sleep quality versus placebo with CBD-only products; a difference was seen with products that also contained THC (da Silva 2025). Research on these topics is ongoing.

How is CBD oil absorbed in the body?

  • Only a small amount reaches the blood: An estimated 6% or so of CBD taken on an empty stomach reaches the bloodstream (Perucca and Bialer 2020).
  • Food makes a big difference: When the approved medicine was taken with a high-fat meal, the total amount reaching the blood rose about 4-fold (Epidiolex label); an analysis pooling studies found a food effect of 2–5-fold (Jang 2024). The European Medicines Agency recommends taking the approved medicine the same way every day (always with food or always on an empty stomach) (EMA).
  • Under the tongue vs. capsule made no difference: In a study of eight healthy men, blood CBD levels were similar with both routes, peaking at about 4 hours; according to the authors, the drops are most likely swallowed (Johnson 2024).
  • It leaves the body slowly: With regular use, it takes 56–61 hours for the amount in the blood to fall by half (Epidiolex label).
  • It builds up in liver disease: In people with impaired liver function, blood CBD levels were 2.5–5 times higher (Jang 2024).

Possible side effects and drug interactions

The most common side effects are drowsiness, diarrhea and decreased appetite. The main things to watch are drug interactions and the liver; with unregulated products, THC not listed on the label and contaminants add extra risk.

  • Drowsiness: In studies of the approved medicine, sleepiness and sluggishness occurred in 32% of people taking the medicine and 11% of those taking placebo; alcohol and sleep medicines can increase this effect (Epidiolex label). More detail: CBD and driving.
  • Liver: In a placebo-controlled study of 201 healthy adults, 5.6% of those taking 5 mg of CBD per kilogram of body weight a day (about 350 mg for a 70 kg person) had liver values above 3 times normal within 4 weeks; this was not seen in the placebo group. Seven people were withdrawn from the study because of possible drug-induced liver injury (Florian 2025).
  • Drug interactions: CBD can slow the breakdown of some medicines in the liver and change their levels in the blood. Examples: the epilepsy medicines clobazam and valproate, and the transplant medicines everolimus (its blood level rose about 2.5-fold), tacrolimus and sirolimus (Epidiolex label). In a patient taking the blood thinner warfarin, a clotting value (INR) rose after CBD was started (Grayson 2018).
  • Pregnancy and breastfeeding: CBD use is not recommended during this time: CBD in pregnancy and breastfeeding.
  • Drug and doping tests: Tests look for THC, not CBD, but many CBD oils contain THC that isn’t listed on the label. Even in a group of 10 people given only CBD, one urine sample tested positive over two weeks of use (Wolinsky 2026). More detail: drug testing, athletes and CBD.
  • Vaping: Inhaling CBD as a vapor has not been shown to be safe: Is CBD vaping harmful?

To enter the medicine you take and see sourced warnings: Check CBD drug interactions (78 medicines). A medicine not being on the list does not mean there is no interaction. All safety topics: Is CBD oil safe?

Label and certificate of analysis

The amount of CBD on the label is often wrong. Of 84 CBD products bought online, only 31% had a CBD content within ±10% of the label; THC was found in 21% of the products (Bonn-Miller 2017). In the UK, this figure was 38% across 29 products, and THC or CBN was measured in 55% of them (Liebling 2022). Among 202 products in the US, the amount of CBD differed from the label by at least 10% in 74% of products (Gidal 2024). In a study of cosmetic and food products, the label accuracy of products saying "tested by an independent laboratory" was no different from those that didn’t say so (Dowd 2025). We could not find a peer-reviewed study measuring the label accuracy of CBD oils sold in Turkey (PubMed, October 20, 2026).

When you look at a label, these points help:

  • Amount: Does it state the total CBD in the bottle in mg and the CBD in 1 ml in mg/ml? "Hemp extract 1000 mg" does not mean the bottle contains 1000 mg of CBD.
  • Batch number and certificate of analysis: Does the batch number on the bottle match the number on the certificate from an accredited (ISO/IEC 17025) laboratory that is independent of the manufacturer?
  • THC: Does the certificate measure Δ9-THC, THCA and "total THC"? "ND" (not detected) does not mean zero; check the detection limit next to it.
  • Contaminants and carrier oil: Are there tests for heavy metals, pesticides and solvent residues, and which oil was used? The approved medicine contains sesame oil and is not used in people who are hypersensitive to sesame (Epidiolex label).
  • Treatment claims: If the label or seller says the product cures a disease, that is a warning sign.
  • Data matrix code (karekod): In Turkey, licensed health and support products carry a data matrix code (karekod) on the box, and the product is tracked in an electronic system (Regulation, 2026).

Step-by-step guide: How to read a CBD label and certificate of analysis

How has it been used in studies?

There is no dose that fits everyone, and we don’t recommend personal doses; if it is used as a medicine, the doctor sets the dose.

  • With the approved medicine, the doctor sets the dose by body weight and monitors the patient with liver tests (Epidiolex label). These doses apply only to that medicine and those conditions.
  • Official limits for CBD sold as food are low. EFSA’s 2026 provisional safe level is about 2 mg a day for a 70 kg adult and applies only to products containing CBD that is at least 98% pure; no level could be set for people under 25, pregnant or breastfeeding women, or people taking medicines (EFSA 2026). The UK Food Standards Agency advises healthy adults to take no more than 10 mg a day (FSA). These are upper safety limits, not personal dose recommendations.
  • To work out how many drops of your own bottle equal the milligrams your doctor prescribed: CBD oil dose and drop calculator.

If you are considering CBD

You can talk with your doctor or pharmacist about: the complaint you’re considering it for and what research has found on it; all the medicines and supplements you take; liver disease or regular alcohol use; pregnancy or breastfeeding; and situations such as driving or drug and doping tests.

In Turkey, hemp-derived products, including CBD, may be sold only in pharmacies (Law No. 7557, January 31, 2026 regulation). The regulation defines four product types: medicinal product (medicine), health product, support product and personal care product. Products in the medicine and health product classes are dispensed with a prescription; no prescription requirement is stated for support products with a THC content of no more than 0.3%. As of October 2026, there is no approved CBD medicine in Turkey; the list of licensed medicines published by TİTCK (Turkish Medicines and Medical Devices Agency) on October 16, 2026 contains no medicine with CBD (TİTCK). Products sold online, on social media or at herbal shops are outside the legal sales channel, and their contents are not checked. The legislation treats hemp seed separately; products containing CBD count as "hemp-derived products." More detail: CBD laws in Turkey (not legal advice).

In other countries: in the US, the FDA approved the licensed CBD medicine in 2018; according to the FDA, CBD cannot be added to food or marketed as a dietary supplement (FDA). In the European Union, CBD in food is considered a "novel food," and the authorization process is ongoing. If you have a side effect, you can report it to the Turkish Pharmacovigilance Center (TÜFAM): how to report a side effect

Conclusion

CBD oil is CBD dissolved in a carrier oil, and what’s in the bottle depends on every step of production. The clearest research results came from the approved medicine, whose content is controlled, in some severe forms of epilepsy; for many other topics, studies are ongoing. If you are considering a product, checking its label and certificate of analysis and talking with your doctor about the medicines you take is a good start.

This article is for information only; it is not a diagnosis or treatment recommendation. We don’t sell products or recommend any product or brand. How we prepare our content: Editorial Policy. Trusted outside sources: Trusted CBD sources. If you spot an error, write to [email protected].

Frequently asked questions

How is CBD oil made?

An extract is taken from the flowers and leaves of the cannabis plant using methods such as ethanol or supercritical carbon dioxide. Heat converts the plant’s CBDA into CBD; the extract is refined if needed and diluted with a carrier oil. Every batch needs to be tested for CBD, THC and contaminants.

What is CBD oil good for?

The clearest result is that the approved CBD medicine reduces seizures in Dravet and Lennox–Gastaut syndromes and in tuberous sclerosis. Research on topics such as pain, sleep and anxiety is ongoing; for most of the topics we have reviewed, results are mixed or there was no clear difference between people who took CBD and those who didn’t. You can look topic by topic in the CBD Guide.

Are CBD oil and hemp seed oil the same thing?

No. Hemp seed oil is a food oil made by pressing the seeds, and it contains only very small amounts of CBD: in 20 seed oils sold in Turkey, CBD came out at no more than about 0.02 mg per milliliter, and small amounts of THC were measured in all but one of the samples. If the bottle doesn’t state how many mg of CBD it contains, the product shouldn’t be considered a CBD oil.

What are the side effects and drug interactions of CBD oil?

The most common side effects are drowsiness, diarrhea and decreased appetite; liver values can also rise. CBD can change the blood levels of some epilepsy medicines, the blood thinner warfarin and transplant medicines. It’s a good idea to talk with your doctor or pharmacist about the medicines you take.

Should CBD oil be placed under the tongue?

In a study of healthy men, there was no difference in blood CBD levels between drops under the tongue and swallowed capsules; the drops are most likely swallowed. What changes the amount reaching the blood the most is whether it is taken with food.

Is CBD oil legal in Turkey?

Hemp-derived products, including CBD, may be sold only in pharmacies (Law No. 7557, January 31, 2026 regulation). Products in the medicine and health product classes are dispensed with a prescription; no prescription requirement is stated for support products with a THC content of no more than 0.3%. As of October 2026, there is no approved CBD medicine in Turkey.

References

Show 36 references
  1. Adams R, Hunt M, Clark JH. Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I. J Am Chem Soc. 1940. DOI 10.1021/ja01858a058
  2. Mechoulam R, Shvo Y. Hashish. I. The structure of cannabidiol. Tetrahedron. 1963. PMID 5879214
  3. Lazarjani MP, et al. Processing and extraction methods of medicinal cannabis: a narrative review. J Cannabis Res. 2021. PMID 34281626
  4. Qamar S, et al. Extraction of medicinal cannabinoids through supercritical carbon dioxide technologies: A review. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID 33639334
  5. Citti C, et al. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J Pharm Biomed Anal. 2018. PMID 29182999
  6. ElSohly MA, et al. Analysis of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil Products. Med Cannabis Cannabinoids. 2020. PMID 34676337
  7. Kacargil CU, et al. Determination of cannabinoids in commercial hemp seeds and hemp seed oil products in Türkiye by LC-MS/MS. Forensic Sci Int. 2026. PMID 41621128
  8. Suraev A, et al. Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: A sub-analysis of the 'PELICAN' study. Epilepsy Behav. 2022. PMID 34954507
  9. Gidal BE, et al. Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples. Front Pharmacol. 2024. PMID 38562466
  10. Bonn-Miller MO, et al. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017. PMID 29114823
  11. Liebling JP, et al. An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom. Cannabis Cannabinoid Res. 2022. PMID 33998849
  12. Dowd AN, et al. Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States. Cannabis Cannabinoid Res. 2025. PMID 39029473
  13. Pamplona FA, et al. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. Front Neurol. 2018. PMID 30258398
  14. Cogan PS. The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Rev Clin Pharmacol. 2020. PMID 32116073
  15. Perucca E, Bialer M. Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications. CNS Drugs. 2020. PMID 32504461
  16. Jang JH, et al. Quantitative summary on the human pharmacokinetic properties of cannabidiol to accelerate scientific clinical application of cannabis. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID 38850302
  17. Johnson DA, et al. Cannabidiol Oil Ingested as Sublingual Drops or Within Gelatin Capsules Shows Similar Pharmacokinetic Profiles in Healthy Males. Cannabis Cannabinoid Res. 2024. PMID 37733294
  18. Devinsky O, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017. PMID 28538134
  19. Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018. PMID 29395273
  20. Moore A, et al. Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms. J Pain. 2024. PMID 37863344
  21. da Silva GHS, et al. Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: A systematic review and meta-analysis of randomised studies. Sleep Med Rev. 2025. PMID 40929927
  22. Florian J, et al. Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial. JAMA Intern Med. 2025. PMID 40622698
  23. Grayson L, et al. An interaction between warfarin and cannabidiol, a case report. Epilepsy Behav Case Rep. 2018. PMID 29387536
  24. Wolinsky D, et al. The acute and chronic pharmacokinetics and pharmacodynamics of oral cannabidiol with and without low doses of delta-9-tetrahydrocannabinol. J Anal Toxicol. 2026. PMID 40704705
  25. Gillham SH, et al. Daily Use of a Broad-Spectrum Cannabidiol Supplement Produces Detectable Concentrations of Cannabinoids in Urine Prohibited by the World Anti-Doping Agency: An Effect Amplified by Exercise. Med Sci Sports Exerc. 2026. PMID 40920736
  26. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Update of the statement on safety of cannabidiol as a novel food. EFSA J. 2026. PMID 41668771
  27. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015/2283. EFSA J. 2026. PMID 42761670
  28. US FDA / DailyMed. EPIDIOLEX (cannabidiol) prescribing information, revision 05/2026.
  29. European Medicines Agency (EMA). Epidyolex product page and product information (authorized September 19, 2019).
  30. World Health Organization (ECDD). Cannabidiol (CBD) Critical Review Report. 2018.
  31. UK Food Standards Agency (FSA). Cannabidiol (CBD) consumer advice.
  32. US FDA. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) (Q&A; accessed October 20, 2026).
  33. Law No. 7557. Official Gazette 32965, July 24, 2025.
  34. Republic of Turkey Ministry of Health. Kenevirden Elde Edilen Ürünlere Dair Yönetmelik (Regulation on Products Derived from Hemp). Official Gazette 33154, January 31, 2026.
  35. Republic of Turkey Ministry of Agriculture and Forestry. Regulation on Hemp Cultivation and Control. Official Gazette 33154, January 31, 2026.
  36. TİTCK. List of Licensed Human Medicinal Products (October 16, 2026).

Related articles